Antidiabetic Effects and Other Health-Related Benefits of Dietary Fatty Acid
- 總結
- Purdue University researchers have developed a novel dietary fatty acid that has a similar biological effect to TZD. This dietary fatty acid significantly improved symptoms of diabetes in animal models including a 50 to 60 percent decline in plasma insulin, triglycerides, and free fatty acids.
- 技術優勢
- Improved treatment of diabetes Insulin independent
- 技術應用
- Medical/Health Diabetes treatment
- 詳細技術說明
- Martha BeluryPurdue Nutrition Science
- *Abstract
-
- *Background
- Thiazolidinediones (TZDs) are a class of oral insulin-sensitizing agents that improve glucose utilization without stimulating insulin release. The Parke-Davis drug Troglitazone(tm) is an example of a TZD currently being used for treating non-insulin dependent diabetes mellitus (NIDDM or type II diabetes mellitus).
- *IP Issue Date
- Mar 21, 2006
- *IP Type
- Utility
- *Stage of Development
- Concept validated through theory, simulation, or models
- *Web Links
- Purdue Office of Technology CommercializationPurdueInnovation and EntrepreneurshipMartha BeluryPurdue Nutrition Science
- 國家
- United States
- 申請號碼
- 7,015,249
- 國家/地區
- 美國
欲了解更多信息，請點擊 這裡
